Hydrochlorothiazide
Product Images NDC 66116-234

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 66116-234). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hctz Structural Formula (Ce37a533 6f4c 4263 A8c6 D61b76d56adb 01)

Hctz Structural Formula (Ce37a533 6f4c 4263 A8c6 D61b76d56adb 01)
Chemical structure of Hydrochlorothiazide, showing the bicyclic ring system with sulfonamide and chlorine substituents, representing the active ingredient of the product by MedVantx, Inc.*
FDA Label Image

Hydrochlorothiazide 25mg Tablet #30 (Ce37a533 6f4c 4263 A8c6 D61b76d56adb 02)

Hydrochlorothiazide 25mg Tablet #30 (Ce37a533 6f4c 4263 A8c6 D61b76d56adb 02)
Packaging label for Hydrochlorothiazide Tablets USP 25mg by MedStart Connect. The label indicates a bottle containing 30 tablets with storage instructions at controlled room temperature 20°-25°C (68°-77°F). It includes directions for dosage and contact information for free shipping and home delivery, with the labeler listed as MedVantx, Inc. and manufacturer Teva Pharmaceuticals USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.